TABLE 3.

Results of in vitro antifungal susceptibility testing for the 33 clinical isolates of Acrophialophora spp. included in the study

Species and parameter	MIC or MEC (μg/ml)a
	AMB	VRC	PSC	ITC	CFGb	AFGb	MFGb	TRB
A. levis (n = 24)
GM	6.77	0.16	0.50	1.15	3.58	1.65	2.64	0.42
Range	1–32	0.06–05	0.25–1	0.5–4	0.25–32	0.25–8	0.25–32	0.125–4
MIC90	32	0.25	1	2	16	4	32	1
A. fusispora (n = 9)
GM	4.22	0.18	0.50	0.85	11.02	2.61	6.46	0.75
Range	2–32	0.125–0.25	0.25–1	0.125–1	4–32	2–8	0.125–32	0.5–1
MIC90	16	0.25	1	1	16	4	32	1
Overall (n = 33)
GM	5.66	0.17	0.49	1	4.98	1.86	3.21	0.51
Range	1–32	0.06–05	0.25–1	0.125–4	0.25–32	0.25–8	0.125–32	0.125–4
MIC90	16	0.25	1	1	16	4	32	1

^aAMB, amphotericin B; VRC, voriconazole; PSC, posaconazole; ITC, itraconazole; CFG, caspofungin; AFG, anidulafungin; MFG, micafungin; TRB, terbinafine.

^bThis column contains MEC data.